St. Jude CEO Confident In PFO Device Despite Competitor’s Failure

St. Jude Medical remains confident in its development-stage patent foramen ovale closure device for prevention of strokes or migraines, despite the well publicized failure of competing PFO device developer NMT Medical, CEO Daniel Starks said.

More from Archive

More from Medtech Insight